Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
数字背后：8位分析师讨论Treace医疗概念股
Treace Medical Concepts (NASDAQ:TMCI) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有8位分析师对Treace Medical Concepts（纳斯达克股票代码：TMCI）进行了分析，揭示了从看涨到看跌的不同视角。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Treace Medical Concepts, revealing an average target of $8.25, a high estimate of $16.00, and a low estimate of $5.50. Observing a downward trend, the current average is 38.62% lower than the prior average price target of $13.44.
分析师为Treace Medical Concepts设定了12个月的目标股价，显示平均目标股价为8.25美元，最高估计为16.00美元，低估值为5.50美元。从下降趋势来看，当前的平均价格比之前的平均目标价13.44美元低38.62％。
Exploring Analyst Ratings: An In-Depth Overview
探索分析师评级：深入概述
A clear picture...
通过对...
登录免费看全文
登录/注册